Transdermal Drug Delivery Systems Market
PUBLISHED: 2024 ID: SMRC25411
SHARE
SHARE

Transdermal Drug Delivery Systems Market

Transdermal Drug Delivery Systems Market Forecasts to 2030 - Global Analysis By Product Type (Transdermal Patches, Gels, Sprays, Microneedles, Iontophoresis Systems and Other Product Types), Component, Technology, Application, End User and By Geography

4.6 (75 reviews)
4.6 (75 reviews)
Published: 2024 ID: SMRC25411

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Transdermal Drug Delivery Systems Market is accounted for $66.2 billion in 2023 and is expected to reach $164.6 billion by 2030 growing at a CAGR of 13.9% during the forecast period. Transdermal drug delivery systems administer medications through the skin, providing a non-invasive and controlled approach. They utilize patches containing drug formulations, allowing gradual absorption into the bloodstream. The skin's outer layer, the stratum corneum, acts as a barrier, regulating drug release. This method minimizes side effects, enhances patient compliance, and maintains steady drug levels. 

According to the World Federation of Neurology's 2023 report, neurological disorders currently rank as the second highest cause of death and the primary cause of disability worldwide. A Global Burden of Disease (GBD) study forecasts a doubling of individuals living with brain diseases by 2050.

Market Dynamics: 

Driver: 

Rising prevalence of chronic diseases

As diabetes, cardiovascular conditions, and chronic pain become more widespread, TDDS emerges as a preferred solution due to its convenience, sustained drug release, and improved patient compliance. The rising need for long-term medication adherence aligns with TDDS's ability to offer non-invasive, user-friendly administration. This trend propels market growth, encouraging pharmaceutical innovation and expanding the scope of transdermal patches into diverse therapeutic areas, creating a dynamic landscape for effective chronic disease management.

Restraint:

Limited range of suitable drugs

The inherent characteristics of certain medications, such as molecular size, lipophilicity, and charge, restrict their effective transdermal delivery. This limitation narrows the scope of applications, hindering the market's growth potential. Pharmaceutical advancements are essential to expand the repertoire of drugs compatible with TDDS. Overcoming this constraint is crucial for realizing the full potential of transdermal delivery in offering non-invasive and patient-friendly alternatives, especially for medications crucial in managing chronic conditions.

Opportunity:

Increasing demand for non-invasive drug delivery

As patients seek convenient, painless alternatives, transdermal patches offer an attractive solution by delivering medications through the skin. This approach enhances patient compliance and comfort, particularly for chronic conditions requiring prolonged treatment. The growing preference for non-invasive options, driven by the desire to reduce needle-related anxieties and improve overall treatment experience, positions transdermal drug delivery as a key player in meeting healthcare demands.

Threat:

High development and regulatory costs 

The complex and stringent regulatory requirements, coupled with extensive research and development expenses, create financial barriers for companies. These costs may deter investment and innovation, limiting the introduction of novel transdermal formulations. Consequently, the market may experience slower growth and reduced accessibility to advanced transdermal technologies.

Covid-19 Impact

Supply chain disruptions, reduced healthcare visits, and diverted resources towards pandemic management have affected market growth. However, the demand for non-invasive drug delivery methods and the focus on home-based treatments have increased interest in transdermal systems. The industry is adapting to address challenges, such as remote patient monitoring and enhancing the efficacy of transdermal drug delivery. The pandemic has accelerated innovation and research in this sector, fostering resilience and potential future growth in the context of evolving healthcare needs and preferences.

The transdermal patches segment is expected to be the largest during the forecast period

The transdermal patches segment is estimated to have a lucrative growth, due to the ease of use, reduced side effects, and improved compliance associated with patches have driven market growth. They offer advantages like controlled drug release, sustained therapeutic levels, and minimized fluctuations. This has led to increased acceptance among patients and healthcare providers. Moreover the Transdermal Drug Delivery Systems market continues to expand as technological advancements address challenges and pave the way for innovative applications, demonstrating a shift towards more efficient, patient-centric drug delivery solutions.

The pain management segment is expected to have the highest CAGR during the forecast period

The pain management segment is anticipated to witness the highest CAGR growth during the forecast period, owing to the demand for a convenient and patient-friendly alternative contributes to the market expansion. Additionally, the development of innovative formulations and technologies enhances the efficacy of transdermal drug delivery, making it an attractive option for pain management. As healthcare providers prioritize safer and more accessible pain therapies, the market for transdermal drug delivery systems is poised to experience continued growth.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the factors such as favourable reimbursement scenarios and rising awareness by government organizations contribute to the region's transdermal drug delivery system market growth. A well-developed healthcare structure covering the citizens' healthcare costs promotes more people opting for treatment in the region. This is expected further to boost the market growth over the forecast period.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, due to its access to healthcare infrastructure, technological advancements, and a substantial focus on research and development within the pharmaceutical industry. Additionally, a higher prevalence of chronic diseases and an aging population in the country have fueled the demand for innovative drug delivery systems like transdermal patches. 

Key players in the market

Some of the key players in the Transdermal Drug Delivery Systems Market include Johnson & Johnson, Novartis AG, Boehringer Ingelheim GmbH, Mylan Pharmaceuticals, Inc., 3M Company, Noven Pharmaceuticals, Inc., Grünenthal, 4P Therapeutics, LLC, AbbVie, Hisamitsu Pharmaceutical co. Inc, Endo International, Purdue Pharma, GlaxoSmithKline, UCB , Viatris Inc., Styker, Grifols, Amgen, Lubrizol Corporation and AdhexPharma 

Key Developments:

In February 2024, Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash. The acquisition, which is subject to customary closing conditions, including a minimum acceptance threshold of 65% of outstanding shares tendered in the takeover offer and regulatory approvals

In January 2024, Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer. In addition, Ambrx’s pipeline and ADC platform present exciting future opportunities to deliver enhanced, precision biologics as transform the treatment of cancer and improve patients’ lives.

In January 2024, CERENOVUS Launches Next Generation Catheter for Revascularization of Patients with Acute Ischemic Stroke and is optimized for effective direct aspiration and for the delivery of compatible stent retrievers,iii including the EMBOTRAP™ III Revascularization Device, into the neurovasculature.

Product Types Covered:
• Transdermal Patches
• Gels
• Sprays
• Microneedles
• Iontophoresis Systems
• Other Product Types
 
Components Covered:
• Controlled Membrane
• Drug Reservoir
• Micro-Reservoir Arrays
• Adhesive System
• Permeation Enhancers
• Carrier Systems

Technologies Covered:
• Matrix Systems 
• Electroporation 
• Sonophoresis 
• Jet Injectors 
• Micro- and Nano-Technology 

Applications Covered:
• Pain Management 
• Hormone Replacement Therapy (HRT) 
• Cardiovascular Disorders 
• Central Nervous System Disorders 
• Smoking Cessation 
• Diabetes 
• Other Applications 

End Users Covered:
• Hospitals & Clinics 
• Ambulatory Surgical Centers 
• Research & Academic Institutes 
• Pharmaceutical Companies 
• Veterinary Care 
• Other End Users 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary           
             
2 Preface            
 2.1 Abstract           
 2.2 Stake Holders          
 2.3 Research Scope          
 2.4 Research Methodology         
  2.4.1 Data Mining         
  2.4.2 Data Analysis         
  2.4.3 Data Validation         
  2.4.4 Research Approach         
 2.5 Research Sources          
  2.5.1 Primary Research Sources        
  2.5.2 Secondary Research Sources        
  2.5.3 Assumptions         
             
3 Market Trend Analysis          
 3.1 Introduction          
 3.2 Drivers           
 3.3 Restraints          
 3.4 Opportunities          
 3.5 Threats           
 3.6 Product Analysis          
 3.7 Technology Analysis         
 3.8 Application Analysis         
 3.9 End User Analysis          
 3.10 Emerging Markets          
 3.11 Impact of Covid-19          
             
4 Porters Five Force Analysis          
 4.1 Bargaining power of suppliers         
 4.2 Bargaining power of buyers         
 4.3 Threat of substitutes         
 4.4 Threat of new entrants         
 4.5 Competitive rivalry          
             
5 Global Transdermal Drug Delivery Systems Market, By Product Type      
 5.1 Introduction          
 5.2 Transdermal Patches         
 5.3 Gels           
 5.4 Sprays           
 5.5 Microneedles          
 5.6 Iontophoresis Systems         
 5.7 Other Product Types         
             
6 Global Transdermal Drug Delivery Systems Market, By Component      
 6.1 Introduction          
 6.2 Controlled Membrane         
 6.3 Drug Reservoir          
 6.4 Micro-Reservoir Arrays         
 6.5 Adhesive System          
 6.6 Permeation Enhancers         
 6.7 Carrier Systems          
             
7 Global Transdermal Drug Delivery Systems Market, By Technology      
 7.1 Introduction          
 7.2 Matrix Systems          
 7.3 Electroporation          
 7.4 Sonophoresis          
 7.5 Jet Injectors          
 7.6 Micro- and Nano-Technology         
             
8 Global Transdermal Drug Delivery Systems Market, By Application      
 8.1 Introduction          
 8.2 Pain Management          
 8.3 Hormone Replacement Therapy (HRT)        
 8.4 Cardiovascular Disorders         
 8.5 Central Nervous System Disorders        
 8.6 Smoking Cessation          
 8.7 Diabetes           
 8.8 Other Applications          
             
9 Global Transdermal Drug Delivery Systems Market, By End User      
 9.1 Introduction          
 9.2 Hospitals & Clinics          
 9.3 Ambulatory Surgical Centers         
 9.4 Research & Academic Institutes        
 9.5 Pharmaceutical Companies         
 9.6 Veterinary Care          
 9.7 Other End Users          
             
10 Global Transdermal Drug Delivery Systems Market, By Geography      
 10.1 Introduction          
 10.2 North America          
  10.2.1 US          
  10.2.2 Canada          
  10.2.3 Mexico          
 10.3 Europe           
  10.3.1 Germany          
  10.3.2 UK          
  10.3.3 Italy          
  10.3.4 France          
  10.3.5 Spain          
  10.3.6 Rest of Europe         
 10.4 Asia Pacific          
  10.4.1 Japan          
  10.4.2 China          
  10.4.3 India          
  10.4.4 Australia          
  10.4.5 New Zealand         
  10.4.6 South Korea         
  10.4.7 Rest of Asia Pacific         
 10.5 South America          
  10.5.1 Argentina         
  10.5.2 Brazil          
  10.5.3 Chile          
  10.5.4 Rest of South America        
 10.6 Middle East & Africa         
  10.6.1 Saudi Arabia         
  10.6.2 UAE          
  10.6.3 Qatar          
  10.6.4 South Africa         
  10.6.5 Rest of Middle East & Africa        
             
11 Key Developments           
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures      
 11.2 Acquisitions & Mergers         
 11.3 New Product Launch         
 11.4 Expansions          
 11.5 Other Key Strategies         
             
12 Company Profiling           
 12.1 Johnson & Johnson          
 12.2 Novartis AG          
 12.3 Boehringer Ingelheim GmbH         
 12.4 Mylan Pharmaceuticals, Inc.         
 12.5 3M Company          
 12.6 Noven Pharmaceuticals, Inc.         
 12.7 Grünenthal          
 12.8 4P Therapeutics, LLC         
 12.9 AbbVie           
 12.10 Hisamitsu Pharmaceutical co. Inc        
 12.11 Endo International          
 12.12 Purdue Pharma          
 12.13 GlaxoSmithKline          
 12.14 UCB            
 12.15 Viatris Inc.          
 12.16 Styker           
 12.17 Grifols           
 12.18 Amgen           
 12.19 Lubrizol Corporation         
 12.20 AdhexPharma          
             
List of Tables            
1 Global Transdermal Drug Delivery Systems Market Outlook, By Region (2021-2030) ($MN)    
2 Global Transdermal Drug Delivery Systems Market Outlook, By Product Type (2021-2030) ($MN)   
3 Global Transdermal Drug Delivery Systems Market Outlook, By Transdermal Patches (2021-2030) ($MN)   
4 Global Transdermal Drug Delivery Systems Market Outlook, By Gels (2021-2030) ($MN)    
5 Global Transdermal Drug Delivery Systems Market Outlook, By Sprays (2021-2030) ($MN)    
6 Global Transdermal Drug Delivery Systems Market Outlook, By Microneedles (2021-2030) ($MN)   
7 Global Transdermal Drug Delivery Systems Market Outlook, By Iontophoresis Systems (2021-2030) ($MN)  
8 Global Transdermal Drug Delivery Systems Market Outlook, By Other Product Types (2021-2030) ($MN)   
9 Global Transdermal Drug Delivery Systems Market Outlook, By Component (2021-2030) ($MN)   
10 Global Transdermal Drug Delivery Systems Market Outlook, By Controlled Membrane (2021-2030) ($MN)  
11 Global Transdermal Drug Delivery Systems Market Outlook, By Drug Reservoir (2021-2030) ($MN)   
12 Global Transdermal Drug Delivery Systems Market Outlook, By Micro-Reservoir Arrays (2021-2030) ($MN)  
13 Global Transdermal Drug Delivery Systems Market Outlook, By Adhesive System (2021-2030) ($MN)   
14 Global Transdermal Drug Delivery Systems Market Outlook, By Permeation Enhancers (2021-2030) ($MN)  
15 Global Transdermal Drug Delivery Systems Market Outlook, By Carrier Systems (2021-2030) ($MN)   
16 Global Transdermal Drug Delivery Systems Market Outlook, By Technology (2021-2030) ($MN)   
17 Global Transdermal Drug Delivery Systems Market Outlook, By Matrix Systems (2021-2030) ($MN)   
18 Global Transdermal Drug Delivery Systems Market Outlook, By Electroporation (2021-2030) ($MN)   
19 Global Transdermal Drug Delivery Systems Market Outlook, By Sonophoresis (2021-2030) ($MN)   
20 Global Transdermal Drug Delivery Systems Market Outlook, By Jet Injectors (2021-2030) ($MN)   
21 Global Transdermal Drug Delivery Systems Market Outlook, By Micro- and Nano-Technology (2021-2030) ($MN)  
22 Global Transdermal Drug Delivery Systems Market Outlook, By Application (2021-2030) ($MN)   
23 Global Transdermal Drug Delivery Systems Market Outlook, By Pain Management (2021-2030) ($MN)   
24 Global Transdermal Drug Delivery Systems Market Outlook, By Hormone Replacement Therapy (HRT) (2021-2030) ($MN) 
25 Global Transdermal Drug Delivery Systems Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)  
26 Global Transdermal Drug Delivery Systems Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN) 
27 Global Transdermal Drug Delivery Systems Market Outlook, By Smoking Cessation (2021-2030) ($MN)   
28 Global Transdermal Drug Delivery Systems Market Outlook, By Diabetes (2021-2030) ($MN)    
29 Global Transdermal Drug Delivery Systems Market Outlook, By Other Applications (2021-2030) ($MN)   
30 Global Transdermal Drug Delivery Systems Market Outlook, By End User (2021-2030) ($MN)    
31 Global Transdermal Drug Delivery Systems Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)   
32 Global Transdermal Drug Delivery Systems Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)  
33 Global Transdermal Drug Delivery Systems Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)  
34 Global Transdermal Drug Delivery Systems Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)  
35 Global Transdermal Drug Delivery Systems Market Outlook, By Veterinary Care (2021-2030) ($MN)   
36 Global Transdermal Drug Delivery Systems Market Outlook, By Other End Users (2021-2030) ($MN)   
             
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials